High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition
Jinyang Cai, Sheeba Jacob, Richard Kurupi and 17 more
Cell Reports · 2022
doi:10.1016/j.celrep.2022.111095 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References69
- 41.
68 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.